Patent · US Active

Pyrazine derivatives and use as PI3K inhibitors

US8877757B2 · kind B2 · utility

0Cited by

0References

28Claims

0Family size

Assignee

MERCK SERONO SA · CH

Inventors

Pascale Gaillard · Saint-Julien-en-Genevois, FR
Anna Quattropani · Rolle, CH
Vincent Pomel · Annecy, FR
Thomas Rueckle · Geneva, CH
Jasna Klicic · Biberach an der Riß, DE
Dennis Church · Versoix, CH

Key dates

Filing date	Aug 31, 2011
Grant date	Nov 4, 2014
Priority date	—
Expiry date	Nov 14, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.